Technical Analysis for INNV - Innovus Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade B 1.92 -8.57% -0.1800
INNV closed down 8.57 percent on Monday, October 21, 2019, on 19 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical INNV trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish -8.57%
50 DMA Support Bullish -8.57%
Inside Day Range Contraction -8.57%
50 DMA Support Bullish -12.33%
Crossed Above 20 DMA Bullish -12.33%
Expansion Pivot Buy Setup Bullish Swing Setup -12.33%

Older signals for INNV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Innovus Pharmaceuticals, Inc. is a pharmaceutical company engaged in the commercialization, licensing, and development of non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases. The Company markets approximately five products in the United States and six in a range of countries around the world through its commercial partners. It has commercial agreements in over 60 countries around the world through its commercial partners. Its marketed products include Zestra, EjectDelay, Sensum+, Zestra Glide, Vesele and Androferti. In addition, the Company has a pipeline of over three additional products, including FlutiCare Over-The-Counter (OTC) for Allergic Rhinitis; Urocis XR, an extended release of Vaccinium Marcocarpon (cranberry), and AndroVit, a supplement to support overall prostate and male sexual health, which is marketed in Europe.
Health Pharmaceutical Pharmaceutical Industry In China Pharmaceuticals Policy Medication Science And Technology In The People's Republic Of China Respiratory Diseases Over The Counter Drug Allergic Rhinitis
Is INNV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.055
52 Week Low 0.0403
Average Volume 7,870
200-Day Moving Average 1.3147
50-Day Moving Average 1.9008
20-Day Moving Average 2.128
10-Day Moving Average 2.06
Average True Range 0.2418
ADX 22.41
+DI 15.7494
-DI 29.2164
Chandelier Exit (Long, 3 ATRs ) 1.7746
Chandelier Exit (Short, 3 ATRs ) 2.1354
Upper Bollinger Band 2.4505
Lower Bollinger Band 1.8055
Percent B (%b) 0.18
BandWidth 30.31015
MACD Line 0.0135
MACD Signal Line 0.0457
MACD Histogram -0.0322
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.0850
Resistance 3 (R3) 2.1033 2.0667 2.0575
Resistance 2 (R2) 2.0667 2.0246 2.0575 2.0483
Resistance 1 (R1) 1.9933 1.9987 1.9750 1.9750 2.0392
Pivot Point 1.9567 1.9567 1.9475 1.9475 1.9567
Support 1 (S1) 1.8833 1.9146 1.8650 1.8650 1.8008
Support 2 (S2) 1.8467 1.8887 1.8375 1.7917
Support 3 (S3) 1.7733 1.8467 1.7825
Support 4 (S4) 1.7550